Showing results (151-160 of 177) with videos related to

Sort By:
Pageof 18
Nature Communications|May 15, 2021
Engineering T cells to enhance 3D migration through structurally and mechanically complex tumor microenvironmentsErdem D Tabdanov, Nelson J Rodríguez-Merced, Alexander X Cartagena-Rivera, et al.
Communications Biology|January 24, 2026
CISH, a key intracellular checkpoint, in comparison and combination to existing and emerging cancer immune checkpointsFlorencia Cano, Alberto Bravo-Blas, Mathilde Colombe, et al.
Blood Advances|August 27, 2021
An irradiated marrow niche reveals a small noncollagenous protein mediator of homing, dermatopontinAshley C Kramer, Yuliana Astuti, Alexis Elfstrum, et al.
Biorxiv : the Preprint Server for Biology|March 18, 2024
Precision Enhancement of CAR-NK Cells through Non-Viral Engineering and Highly Multiplexed Base EditingMinjing Wang, Joshua B Krueger, Alexandria K Gilkey, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|September 12, 2017
Rapid generation of Col7a1-/- mouse model of recessive dystrophic epidermolysis bullosa and partial rescue via immunosuppressive dermal mesenchymal stem cellsBeau R Webber, Kyle T O'Connor, Ron T McElmurry, et al.
Frontiers in Immunology|March 27, 2026
Midgestational injection of highly expanded human CD34+ cells increases lineages of human immune cells and supports thymic development in RAG2-/-IL2RG-/Y SCID pigsAhlea M Forster, Amanda Ahrens Kress, Matti Kiupel, et al.
Nature Biomedical Engineering|December 13, 2023
Cas9-induced targeted integration of large DNA payloads in primary human T cells via homology-mediated end-joining DNA repairBeau R Webber, Matthew J Johnson, Joseph G Skeate, et al.
Nature Communications|November 21, 2019
Highly efficient multiplex human T cell engineering without double-strand breaks using Cas9 base editorsBeau R Webber, Cara-Lin Lonetree, Mitchell G Kluesner, et al.
Nature Communications|April 24, 2021
CRISPR-Cas9 cytidine and adenosine base editing of splice-sites mediates highly-efficient disruption of proteins in primary and immortalized cellsMitchell G Kluesner, Walker S Lahr, Cara-Lin Lonetree, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 10, 2019
A Genetically Engineered Primary Human Natural Killer Cell Platform for Cancer ImmunotherapyEmily J Pomeroy, John T Hunzeker, Mitchell G Kluesner, et al.
Pageof 18